| Market Cap | 9.48M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -21.12M | Forward P/E | -0.07 | EPS next Y | - | 50D Avg Chg | -31.00% |
| Sales | 8.23M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -92.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -98.00% |
| Recommedations | 3.00 | Quick Ratio | 0.03 | Shares Outstanding | 113.81K | 52W Low Chg | 27.00% |
| Insider Own | 2.41% | ROA | -28.97% | Shares Float | 6.89M | Beta | 0.97 |
| Inst Own | 2.73% | ROE | - | Shares Shorted/Prior | 139.95K/65.56K | Price | 2.09 |
| Gross Margin | 37.57% | Profit Margin | -275.67% | Avg. Volume | 504,352 | Target Price | - |
| Oper. Margin | -137.53% | Earnings Date | - | Volume | 1,923,475 | Change | 3.98% |
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceuticals and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, and soups and shakes, as well as vitamins and supplement powders, tablets, and soft gels under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the GSP brand for athletes and active lifestyle consumers. The company provides various nutritional products, such as antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products; and operates a cost per action/cost per acquisition network for digital marketers for product sale and lead generation. It retails its products through online market platforms and stores. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. The company was founded in 2002 and is based in Miami, Florida.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Trilogy Capital Group, LLC | 10% Owner 10% Owner | Dec 16 | Sell | 0.2570 | 1,161,000 | 298,377 | 5,229,000 | 12/20/22 |
| Cervantes Alfonso J. JR | Executive Chairman Executive Chairman | Dec 16 | Sell | 0.2570 | 1,161,000 | 298,377 | 5,229,000 | 12/20/22 |
| Altbach Ronald S. | Director Director | Jun 09 | Option | 0.01 | 200,000 | 2,000 | 250,000 | 06/29/22 |
| Altbach Ronald S. | Director Director | Jun 09 | Sell | 0.44 | 4,505 | 1,982 | 245,495 | 06/29/22 |